ethinyl estradiol has been researched along with etonogestrel in 109 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (3.67) | 18.7374 |
| 1990's | 22 (20.18) | 18.2507 |
| 2000's | 41 (37.61) | 29.6817 |
| 2010's | 36 (33.03) | 24.3611 |
| 2020's | 6 (5.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Jung-Hoffmann, C; Kuhl, H; Storch, A | 1 |
| Coelingh-Bennink, HJ; Davies, GC; Dieben, TO; Feng, LX; Newton, JR | 2 |
| Fitzner, M; Jung-Hoffmann, C; Kuhl, H | 2 |
| Back, D; Kuhnz, W; Louton, T; Power, J; Schütt, B | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Jung-Hoffmann, C; Kuhl, H | 1 |
| Alapiessa, U; Apter, D; Assendorp, R; Cacciatore, B; Stenman, UH | 1 |
| Apter, D; Timmer, CJ; Voortman, G | 1 |
| Odlind, V; Olsson, SE | 1 |
| al-Yacoub, G; Kuhnz, W; Pfeffer, M | 1 |
| Bosch, AM; Hasenack, HG; Käär, K | 1 |
| Back, DJ; Grimmer, SF; Orme, ML; Shenoy, N | 1 |
| Heidt, F; Jung-Hoffmann, C; Kuhl, H | 1 |
| de Leede, LG; de Nijs, H; Govers, CP | 1 |
| Fitzner, M; Gross, W; Jung-Hoffmann, C; Kuhl, H; März, W | 1 |
| Bocchinfuso, WP; Hammond, GL; Orava, M; Smith, CL; van den Ende, A; van Enk, A | 1 |
| Back, DJ; Daume, E; Hammerstein, J; Neiss, A; Power, J; Schindler, AE; Simon, A; Winkler, U | 1 |
| Archer, DF; Lammers, P; Timmer, CJ | 1 |
| Levrier, M | 1 |
| Schindler, AE | 1 |
| Back, DJ; Rudland, PS; Wild, MJ | 1 |
| Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
| Archer, DF; Charnock-Jones, DS; Leslie, S; Macpherson, AM; Makkink, WK; Smith, SK | 1 |
| Buicu, C; Gaspard, U; van den Brûle, F | 1 |
| Colau, JC | 1 |
| Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
| Mulders, TM; Timmer, CJ | 1 |
| Archer, DF; Charnock-Jones, DS; Leslie, S; Macpherson, AM; Makkink, WK; Sharkey, AM; Smith, SK | 1 |
| Apter, D; Dieben, TO; Mulders, TM; Roumen, FJ | 1 |
| Dieben, TO; Mulders, TM | 1 |
| Kruft, MA; van Laarhoven, JA; Vromans, H | 1 |
| Apter, D; Dieben, TO; Roumen, FJ | 1 |
| Abetz, L; de la Loge, C; Novák, A; van der Meulen, EA | 1 |
| Milsom, I | 1 |
| Killick, S | 1 |
| Roumen, F | 1 |
| Vree, M | 1 |
| Szarewski, A | 1 |
| Haring, T; Mulders, TM | 1 |
| Hamerlynck, JV; Knuist, M | 1 |
| Evans, SL; Forinash, AB | 1 |
| Dieben, TO; Mulders, TM; van den Heuvel, MW; Verhoeven, CH | 1 |
| Dieben, TO; Verhoeven, CH | 1 |
| Dieben, TO; Klimscheffskij, R; Tuppurainen, M; Venhola, M | 1 |
| Acunzo, G; Bramante, S; Di Carlo, C; Di Spiezio Sardo, A; Greco, E; Guida, M; Nappi, C; Pellicano, M; Sparice, S; Tommaselli, GA | 1 |
| Dogterom, P; Thomsen, T; van den Heuvel, MW | 1 |
| Dieben, T; Duijkers, I; Klipping, C; Kuukankorpi, A; Mäkäräinen, L; Massai, R | 1 |
| Hout, Ji; Miller, L; Verhoeven, CH | 1 |
| Sarkar, NN | 1 |
| O'Connell, KJ; Osborne, LM; Westhoff, C | 1 |
| Findlay, JK; Fraser, IS; Hickey, M; O'Connor, V; Palmer, D; Salamonsen, LA; Weisberg, E | 2 |
| Dieben, TO; Roumen, FJ | 1 |
| Hoomans, EH; op ten Berg, MM; Roumen, FJ | 1 |
| Aubeny, E; Bastianelli, C; Birkhäuser, MH; Bjertnaes, A; Gruber, CJ; Knudsen, T; Lete, I; Lindh, I; Milsom, I; Rokstad, K | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Prezioso, A | 1 |
| Barbosa, R; Barreiros, FA; de Araújo, FF; Guazzelli, CA | 1 |
| Arias, RD; Nucatola, DL; Wagner, MS | 1 |
| Blumenthal, P; Madden, T | 1 |
| Bauer, S; Brattström, A; Kunter, U; Roots, I; Will-Shahab, L | 1 |
| Abbiati, A; Barbara, G; Bianchi, S; Fedele, L; Somigliana, E; Vercellini, P | 1 |
| Barbosa, R; Barreiros, FA; de Araújo, FF; Guazzelli, CA; Moron, AF | 1 |
| Airee, A; Cobb, D; Guirguis, AB; Zingone, MM | 1 |
| Bifulco, G; Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Nappi, C | 1 |
| Barbosa, R; Barreiros, FA; de Araújo, FF; de Assis, F; Guazzelli, CA | 1 |
| Weisberg, E | 1 |
| Dunne, C; Firoz, T; Malyuk, D | 1 |
| Briones-Landa, CH; Bustillos-Alamilla, E; Hernández-Ruiz, MA; Zepeda-Zaragoza, J | 1 |
| Hund, M; Merki-Feld, GS | 1 |
| Darney, P; Kerns, J | 1 |
| Ding, CG; Ge, QH; Liu, XF; Zhi, XJ; Zhou, Z | 1 |
| Araujo, FF; Barbieri, M; Barbosa, R; Barreiros, FA; Guazzelli, CA; Torloni, MR | 1 |
| Kolacki, C; Rocco, V | 1 |
| Barbieri, M; Barbosa, R; Barreiros, FA; Guazzelli, CA; Torloni, MR | 1 |
| Burger, HG; Croxatto, HB; Findlay, JK; Fraser, IS; Weisberg, E | 1 |
| Cremers, S; Dragoman, M; Mayeda, ER; Petrie, K; Thomas, T; Torgal, AH; Westhoff, CL | 1 |
| Basha, M; Burrows, LJ; Goldstein, AT | 1 |
| Calhoun, A; Ford, S; Pruitt, A | 1 |
| Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
| Kallio, S; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS; Vaskivuo, T | 1 |
| Cremers, S; Dragoman, M; Petrie, K; Thomas, T; Torgal, A; Westhoff, CL | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Arangino, S; Cagnacci, A; Napolitano, A; Volpe, A; Zanin, R | 1 |
| Cuesta, MC; Guerra, S; Lete, I; Marín, JM | 1 |
| Ahluwalia, J; Ananworanich, J; Chaithongwongwatthana, S; Cremers, S; Kerr, S; Landolt, NK; Lange, JM; Phanuphak, N; Pinyakorn, S; Thammajaruk, N; Thomas, T; Thongpaeng, P; Ubolyam, S | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
| Cibarelli, F; Di Spiezio Sardo, A; Gallo, A; Guida, M; Palumbo, AR; Troisi, J | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Chang, Q; Di, W; Fan, GS; Korver, T; Marintcheva-Petrova, M; McCrary Sisk, C; Qin, Y; Ren, M; Su, P; Wang, G; Wu, S; Yacik, C | 1 |
| Camões, S; Lopes, C; Rocha, J; Sampaio, J; Tiago, P | 1 |
| Goel, N; Priya, K; Rajaram, S | 1 |
| Adler, Z; Balucani, C; Levine, SR; Piran, P; Selvan, P; Tark, B | 1 |
| Lapuente, O; Lete, I; López-Picado, A | 1 |
| Desai, M; Evans-Strickfaden, T; Haaland, RE; Holder, A; Huey, MJ; Humwa, F; Makanga, M; McLellan-Lemal, E; Nyagol, B; Oyaro, B; Williams, T | 1 |
| Chaudhary, DV; Gonzalez, FJ; Nair, SG; Patel, BM; Patel, DP; Singhal, P | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Cruz, SM; Duijkers, I; Fayad, GN; Frenkl, TL; Heger-Mahn, D; Klipping, C; Korver, T | 1 |
| Aweeka, F; Baker, P; Berzins, B; Cohn, SE; Coombs, R; Coughlin, K; Cramer, YS; Gingrich, D; Godfrey, C; Haas, DW; Moran, LE; Rosenkranz, SL; Scarsi, KK; Zorrilla, CD | 1 |
| Díez, C; Matilla, S; Mueller, A; Regidor, PA | 1 |
| Artini, PG; Battaglia, B; Battaglia, C; Casadio, P; Rizzo, R | 1 |
| Colli, E; Müller, A; Regidor, PA; Sailer, M | 1 |
| Hladik, F; Hughes, SM; Johnston, C; Marrazzo, J; Micks, E; Pandey, U | 1 |
| Algorta, J; Colli, E; Mayr, M; Palacios, S; Regidor, PA; Roemer, T | 1 |
17 review(s) available for ethinyl estradiol and etonogestrel
| Article | Year |
|---|---|
[Vaginal contraception with ovarian steroids].
Topics: Administration, Intravaginal; Clinical Trials as Topic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pessaries; Progesterone Congeners | 1993 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Complete and robust ovulation inhibition with NuvaRing.
Topics: Biological Availability; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Ovulation Inhibition; Patient Compliance; Vinyl Compounds | 2002 |
Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
Topics: Consumer Product Safety; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pregnancy; Pregnancy Rate; Vinyl Compounds | 2002 |
Lower hormone dosage with improved cycle control.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Incidence; Menstrual Cycle; Menstruation Disturbances; Vinyl Compounds | 2002 |
High acceptability and satisfaction with NuvaRing use.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Patient Satisfaction; Vinyl Compounds | 2002 |
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ovulation; Patient Satisfaction; Randomized Controlled Trials as Topic | 2005 |
The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Topics: Animals; Contraception; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2007 |
Contraceptive vaginal ring.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ovulation; Patient Compliance; Patient Satisfaction; Treatment Outcome | 2007 |
Vaginal ring contraception.
Topics: Anti-Retroviral Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Equipment Failure; Ethinyl Estradiol; Female; Humans; Patient Satisfaction | 2011 |
The combined vaginal contraceptive ring, nuvaring, and cerebral venous sinus thrombosis: a case report and review of the literature.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Intrauterine Devices, Medicated; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 2012 |
The effects of hormonal contraceptives on female sexuality: a review.
Topics: Acne Vulgaris; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; Libido; Medroxyprogesterone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin; Sexuality; Vulva; Vulvodynia | 2012 |
Vaginal health in contraceptive vaginal ring users - A review.
Topics: Candidiasis, Vulvovaginal; Colposcopy; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Vagina; Vaginal Discharge; Vaginal Diseases | 2013 |
Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans | 2017 |
Safety, efficacy and quality of life of the novel vaginal contraceptive ring containing etonogestrel/ethinylestradiol 11.0/3.474 mg after 3 years of "real life" experience.
Topics: Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Quality of Life; Time Factors | 2020 |
42 trial(s) available for ethinyl estradiol and etonogestrel
| Article | Year |
|---|---|
Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Multivariate Analysis; Norpregnenes; Progesterone Congeners; Uterine Hemorrhage | 1990 |
Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol.
Topics: Adult; Androstenedione; Contraceptive Devices, Female; Dehydroepiandrosterone; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Ovary; Progesterone; Progestins; Testosterone | 1990 |
Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel.
Topics: Adult; Apolipoprotein A-I; Cholesterol; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Progesterone Congeners; Triglycerides | 1995 |
Prodrug versus drug effects of 150 micrograms desogestrel or 3-keto-desogestrel in combination with 30 micrograms ethinylestradiol on hormonal parameters: relevance of the peak serum level of 3-keto-desogestrel.
Topics: Adult; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Liver; Prodrugs; Progesterone Congeners; Sex Hormone-Binding Globulin; Time Factors | 1995 |
Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Sex Hormone-Binding Globulin; Transcortin | 1994 |
Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives.
Topics: Adolescent; Adult; Blood Proteins; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Protein Binding; Sex Hormone-Binding Globulin | 1993 |
The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception.
Topics: Adult; Contraception; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Progesterone Congeners | 1993 |
The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium.
Topics: Adolescent; Adult; Cell Count; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Endometrium; Endothelial Growth Factors; Endothelium; Ethinyl Estradiol; Female; Humans; Immunohistochemistry; Lymphokines; Menstrual Cycle; Menstruation; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Reference Values; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinyl Compounds | 1999 |
Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Vinyl Compounds | 2000 |
Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Follicle; Ovulation; Progesterone; Time Factors; Ultrasonography; Vinyl Compounds | 2001 |
Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Patient Compliance; Patient Satisfaction; Sensitivity and Specificity; Vagina; Vinyl Compounds | 2002 |
The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
Topics: Adolescent; Adult; Coitus; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Male; North America; Patient Satisfaction; Surveys and Questionnaires; Vagina; Vinyl Compounds | 2003 |
Complete and robust ovulation inhibition with NuvaRing.
Topics: Biological Availability; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Ovulation Inhibition; Patient Compliance; Vinyl Compounds | 2002 |
The combined contraceptive ring NuvaRing and spermicide co-medication.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Interactions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Nonoxynol; Spermatocidal Agents; Vinyl Compounds | 2003 |
The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; Miconazole | 2004 |
The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Administration Routes; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Tampons, Surgical | 2004 |
The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Male; Patient Satisfaction; Prospective Studies; Sexual Behavior; Sexuality; Surveys and Questionnaires | 2005 |
Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Contraceptive Agents, Female; Cross-Over Studies; Delayed-Action Preparations; Desogestrel; Doxycycline; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans | 2005 |
The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone and Bones; Bone Density; Contraceptive Agents, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Premenopause; Time Factors | 2005 |
Extended regimens of the contraceptive vaginal ring: a randomized trial.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Pregnancy; Progesterone Congeners; Uterine Hemorrhage | 2005 |
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain | 2005 |
A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Middle Aged; Mifepristone; Placebos | 2006 |
Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
Topics: Administration, Intravaginal; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Hysterectomy; Middle Aged; Progesterone Congeners; Tissue Distribution; Uterus | 2006 |
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Topics: Administration, Oral; Adult; Androstenes; Body Composition; Body Weight; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Intrauterine Devices; Menstrual Cycle; Patient Compliance | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive.
Topics: Administration, Oral; Adult; Area Under Curve; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Herb-Drug Interactions; Humans; Hypericum; Plant Extracts; Tablets | 2009 |
Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Choice Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Norgestrel; Pain Measurement; Patient Satisfaction; Uterine Diseases; Young Adult | 2010 |
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Mifepristone; Uterine Hemorrhage | 2009 |
Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Topics: Absorptiometry, Photon; Amino Acids; Analysis of Variance; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Prospective Studies | 2010 |
[Combined hormonal contraception in cycles artificially extended].
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenes; Breast Diseases; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Norgestrel; Patient Acceptance of Health Care; Prospective Studies; Time Factors; Uterine Hemorrhage; Young Adult | 2010 |
A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Drug Implants; Drug Interactions; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinization; Menstrual Cycle; Middle Aged; Mifepristone; Ovary; Ovulation Inhibition; Ultrasonography; Uterine Hemorrhage; Viscosity; Young Adult | 2011 |
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Endometrium; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Obesity; Ovarian Follicle; Prospective Studies; Young Adult | 2012 |
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Topics: Administration, Cutaneous; Adult; Anti-Mullerian Hormone; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Norgestrel; Ovarian Follicle; Oximes; Pituitary Gland; Prospective Studies; Young Adult | 2013 |
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Obesity; Ovarian Follicle; Prospective Studies; Vagina; Young Adult | 2013 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.
Topics: Adolescent; Adult; China; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Medication Adherence; Metrorrhagia; Young Adult | 2016 |
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Outcome Assessment, Health Care; Ovulation Inhibition | 2018 |
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
Topics: Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Cyclopropanes; Cytochrome P-450 CYP2B6; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Genetic Association Studies; Genotype; HIV Infections; Humans; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Ritonavir; Vagina | 2020 |
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators.
Topics: Adult; Antigens, Differentiation, T-Lymphocyte; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Immunity, Mucosal; Menstrual Cycle; Middle Aged | 2021 |
51 other study(ies) available for ethinyl estradiol and etonogestrel
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel.
Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Kinetics; Luteinizing Hormone; Sex Hormone-Binding Globulin; Transcortin | 1992 |
Ovarian activity and bleeding patterns during extended continuous use of a combined contraceptive vaginal ring.
Topics: Administration, Intravaginal; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Endometrium; Estradiol; Ethinyl Estradiol; Female; Hemorrhage; Humans; Ovulation; Progesterone Congeners; Silicone Elastomers; Time Factors | 1992 |
The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
Topics: Administration, Intravaginal; Animals; Chlamydia trachomatis; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Norpregnenes; Saccharomyces cerevisiae; Time Factors; Trichomonas vaginalis; Vagina | 1992 |
Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1991 |
Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design.
Topics: Adult; Biological Availability; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes | 1991 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings.
Topics: Administration, Oral; Adult; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Injections, Intravenous; Metabolic Clearance Rate; Norpregnenes; Progesterone Congeners; Radioimmunoassay | 1990 |
Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin | 1990 |
Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
Topics: Blood Proteins; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Protein Binding; Radioimmunoassay | 1990 |
Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel.
Topics: Administration, Oral; Biotransformation; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1986 |
Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel.
Topics: Administration, Oral; Adult; Biological Availability; Desogestrel; Ethinyl Estradiol; Female; Humans; Injections, Intravenous; Kinetics; Norpregnenes | 1987 |
Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrel.
Topics: Adult; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Sex Hormone-Binding Globulin; Time Factors | 1988 |
A multi-compartment vaginal ring system for independently adjustable release of contraceptive steroids.
Topics: Administration, Intravaginal; Administration, Topical; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Contraceptive Devices; Desogestrel; Equipment Design; Ethinyl Estradiol; In Vitro Techniques; Norpregnenes; Steroids | 1986 |
Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Sex Hormone-Binding Globulin | 1994 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.
Topics: Cell Count; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Endometrium; Endothelial Growth Factors; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Immunohistochemistry; Lymphokines; Menstrual Cycle; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinyl Compounds | 2000 |
Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
Topics: Cervix Uteri; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Compliance; Vinyl Compounds | 2001 |
In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Interactions; Ethinyl Estradiol; Solubility; Time Factors; Vinyl Compounds | 2002 |
Introduction. NuvaRing.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Vinyl Compounds | 2002 |
[Vaginal contraception: new form of administration of hormonal contraception].
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pregnancy | 2003 |
The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Netherlands; Patient Compliance; Patient Satisfaction | 2006 |
Contraception: an international perspective.
Topics: Contraception; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Administration Routes; Ethinyl Estradiol; Female; Humans; Internationality | 2006 |
Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Menstruation Disturbances; Prospective Studies | 2007 |
Extended regimens of the vaginal contraceptive ring: cycle control.
Topics: Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Young Adult | 2009 |
Probable drug interaction between warfarin and hormonal contraceptives.
Topics: Adult; Anticoagulants; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; International Normalized Ratio; Norethindrone; Warfarin | 2009 |
Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects.
Topics: Adolescent; Adult; Chi-Square Distribution; Contraceptive Devices, Female; Desogestrel; Drug Administration Schedule; Dysmenorrhea; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Prospective Studies; Time Factors; Treatment Outcome; Weight Gain | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Cerebral venous sinus thrombosis in a woman using the etonogestrel-ethinyl estradiol vaginal contraceptive ring: a case report.
Topics: Adult; Brain Death; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Fatal Outcome; Female; Humans; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 2010 |
Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Observation; Ovulation; Patient Satisfaction; Switzerland; Young Adult | 2010 |
[Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].
Topics: Animals; Chromatography, Liquid; Desogestrel; Ethinyl Estradiol; Norpregnenes; Rabbits; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2010 |
Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Prospective Studies; Young Adult | 2011 |
Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Prospective Studies; Triglycerides | 2012 |
The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Migraine with Aura; Pilot Projects; Retrospective Studies; Treatment Outcome | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study.
Topics: Administration, Intravaginal; Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Heart Rate; Humans; Hypertension; Prospective Studies; Severity of Illness Index; Young Adult | 2013 |
Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Nevirapine; Prospective Studies | 2014 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraception Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Personal Satisfaction; Sexual Behavior; Sexuality; Time Factors | 2014 |
Autoimmune progesterone dermatitis: Case report of an unexpected treatment reaction.
Topics: Administration, Intravaginal; Adult; Androstenes; Autoimmune Diseases; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Dermatitis; Desogestrel; Ethinyl Estradiol; Female; Humans; Luteal Phase; Progesterone; Urticaria | 2017 |
Stroke and Etonogestrel/Ethinyl Estradiol Ring (NuvaRing): Clinical, Radiological, and Prognostic Features.
Topics: Adolescent; Adult; Cerebral Angiography; Contraceptive Agents, Female; Databases, Factual; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Prognosis; Stroke; Tomography Scanners, X-Ray Computed; Young Adult | 2017 |
Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Kenya; Patient Compliance; United States | 2017 |
Simultaneous determination of etonogestrel and ethinyl estradiol in human plasma by UPLC-MS/MS and its pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Desogestrel; Ethinyl Estradiol; Female; Humans; Limit of Detection; Linear Models; Reproducibility of Results; Tandem Mass Spectrometry | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Elution from intact and broken vaginal contraceptive rings: an in vitro study.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Materials Testing | 2020 |
Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
Topics: Adult; Blood Glucose; Brachial Artery; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Longitudinal Studies; Metformin; Ophthalmic Artery; Pilot Projects; Polycystic Ovary Syndrome; Retrospective Studies; Ultrasonography, Doppler; Vasodilation; Young Adult | 2020 |
Multicenter, international observational study on quality of life and acceptability of a vaginal contraceptive ring containing etonogestrel/ethinylestradiol 11.00/3.474 mg over six months of use.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Quality of Life | 2022 |